Lidocaine Skin Patch (Lidopat   5%) Is Effective in the Treatment of XXXX : A Prospective Double-Blinded and Vehicle-Controlled Study.

@entity1 @entity174 @entity6882 @entity158 @entity130
OBJECTIVE: The purpose of this study was to determine the efficacy of the Lidopat   5% skin patch in relieving rib @entity158 . SUBJECTS AND METHODS: From June 2009 to May 2011, 44 @entity130 @entity1 with @entity174 were enrolled in this study and randomized in a double-blind method into 2 groups. The experimental group (group E: 27 @entity1 ) used a Lidopat   5% skin patch at the @entity130 site and took an oral analgesic drug for @entity158 relief. The placebo group (group P: 17 @entity1 ) used a placebo vehicle patch and an oral analgesic drug. RESULTS: The mean age, weight and hospital stay of @entity1 were 56.8    13.8 years, 67.4    12.6 kg and 6.34    1.3 days, respectively. In the first 4 days, there were no significant differences in @entity158 scores between the groups (p > 0.05). After the 5th day, the average @entity158 score was significantly less in group E (mean 1.5) than in group P (mean 3.10; p < 0.05). There was no significant difference in the number of @entity174 between groups (p = 0.904). The use of @entity6882 and the length of hospital stay (6.0 vs. 6.9 days) were both significantly less in group E (p = 0.043 and 0.009, respectively). CONCLUSION: In this study, the use of the Lidopat   5% skin patch in @entity1 with @entity174 alleviated @entity158 and shortened the hospital stay, and a lower dose of @entity158 -relieving medication was used.
